Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials

CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials

(2013) Kenneth F. Schulz   ANNALS OF INTERNAL MEDICINE

High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men

(2013) Satya Dash et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Role of the laboratory in diabetes diagnosis and screening—The 2013 CDA CPGs

(2013) Zubin Punthakee   CLINICAL BIOCHEMISTRY

Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies

(2013) I. Muraki et al.   BMJ-British Medical Journal

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

(2012) João Tomé-Carneiro et al.   AMERICAN JOURNAL OF CARDIOLOGY

Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance

(2012) Jun Yoshino et al.   Cell Metabolism

High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition

(2012) M. M. Poulsen et al.   DIABETES

Resveratrol Attenuates Obesity-Associated Peripheral and Central Inflammation and Improves Memory Deficit in Mice Fed a High-Fat Diet

(2012) B. T. Jeon et al.   DIABETES

Diagnosis and Classification of Diabetes Mellitus

(2012)   DIABETES CARE

By the numbers: New estimates from the IDF Diabetes Atlas Update for 2012

(2012) Leonor Guariguata   DIABETES RESEARCH AND CLINICAL PRACTICE

Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial

(2012) Joao Tomé-Carneiro et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus

(2012) Jayesh Kumar Bhatt et al.   NUTRITION RESEARCH

Anti-diabetic effects of resveratrol

(2011) Tomasz Szkudelski et al.   Annals of the New York Academy of Sciences

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

(2011) Pál Brasnyó et al.   BRITISH JOURNAL OF NUTRITION

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

(2011) Silvie Timmers et al.   Cell Metabolism

IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030

(2011) David R. Whiting et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives

(2011) Lei Chen et al.   Nature Reviews Endocrinology

Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment

(2011) Keisuke Fujitaka et al.   NUTRITION RESEARCH

Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study

(2010) K. Makrilakis et al.   DIABETIC MEDICINE

Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats

(2010) P. Palsamy et al.   JOURNAL OF CELLULAR PHYSIOLOGY

AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol

(2009) J.-H. Um et al.   DIABETES

Central Administration of Resveratrol Improves Diet-Induced Diabetes

(2009) Giorgio Ramadori et al.   ENDOCRINOLOGY

Sirtuins: Novel targets for metabolic disease in drug development

(2008) Wei-jian Jiang   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats

(2008) P. Palsamy et al.   BIOMEDICINE & PHARMACOTHERAPY

Overexpression of SIRT1 Protects Pancreatic  -Cells Against Cytokine Toxicity by Suppressing the Nuclear Factor- B Signaling Pathway

(2008) J.-H. Lee et al.   DIABETES

Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium

(2008) S. Varma Penumathsa et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol

(2008) Arion Kennedy et al.   JOURNAL OF LIPID RESEARCH

A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice

(2008) Jamie L. Barger et al.   PLoS One

The insulin-suppressive effect of resveratrol — An in vitro and in vivo phenomenon

(2007) Tomasz Szkudelski   LIFE SCIENCES